Trademark Encyclopedia

Information about trademarks

Search for trademarks:

• 0
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• A
• B
• C
• D
• E
• F
• G
• H
• I
• J
• K
• L
• M
• N
• O
• P
• Q
• R
• S
• T
• U
• V
• W
• X
• Y
• Z

Table of contents:

• Document 85371627 overview
• GOODS AND/OR SERVICES CLASS
• FOREGIN REGISTRATION
• PROSECUTION HISTORY
• Document 86293514 overview

---

---

The "NUCALA" trademark, serial number 85371627 , was filed on 14th of July 2011 with a mark drawing code of 4000 and its transaction date is 85371627. The attorney assigned is Maribeth Day Case, attorney docket number TMR/5079019/. Since 14th of February 2012, the document can be found in the M80 law office in the publication and issue section. The employee responsible is ZAK, HENRY S and the date it was published for opposition on 12/20/2011. The status of the trademark was checked last on 02/14/2012.

The corresponded responsible for this trademark is MARIBETH DAY CASE, located at GLAXOSMITHKLINE, 5 MOORE DR, RESEARCH TRIANGLE PARK, NC 27709-0183.

The state or country where the trademark was organized is by Glaxo Group Limited. The legal entity type behing it is a Corporation, located at Berkeley Avenue, Greenford, Middlesex, zip UB60NN.Other trademarks by this applicant: INNOFLO, INOFLO, EDOZAB.

GOODS AND/OR SERVICES
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
U.S. Class	052 - Detergents and Soaps
Class Status	6 - Active
Status Date	07/19/2011
Primary Code	005
Goods codes
GS0051	(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

FOREGIN REGISTRATION
Foreign Filing Date	06/02/2011
Foreign Application Number	2583263
Country	GB

PROSECUTION HISTORY
Date	Description	Type	Code
02/14/2012	NOA E-MAILED - SOU REQUIRED FROM APPLICANT	E	NOAM
12/20/2011	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	E	NPUB - NOTICE OF PUBLICATION
12/20/2011	PUBLISHED FOR OPPOSITION	A - Allowance for Publication	PUBO - PUBLISHED FOR OPPOSITION
11/30/2011	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	E	NONP
11/14/2011	ELECTRONIC RECORD REVIEW COMPLETE	O - Outgoing Correspondence	FIXD
11/11/2011	ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED	O - Outgoing Correspondence	ERRR
11/04/2011	APPROVED FOR PUB - PRINCIPAL REGISTER	P	CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER
11/03/2011	ASSIGNED TO EXAMINER	D - Assigned to Examiner	DOCK - ASSIGNED TO EXAMINER
07/19/2011	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	I - Incoming Correspondence	NWOS
07/18/2011	NEW APPLICATION ENTERED IN TRAM	I - Incoming Correspondence	NWAP - NEW APPLICATION ENTERED IN TRAM

Some parts © 2024 Advameg, Inc.